Provided by Tiger Fintech (Singapore) Pte. Ltd.

Collegium Pharmaceutical

29.88
+0.05000.17%
Post-market: 29.880.00000.00%16:10 EDT
Volume:287.21K
Turnover:8.55M
Market Cap:960.41M
PE:23.82
High:29.99
Open:29.74
Low:29.26
Close:29.83
Loading ...

Director’s Bold Move: Major Stock Sale at Collegium Pharmaceutical

TIPRANKS
·
12 Jun

Director John Gordon Freund Reports Disposal of Common Shares of Collegium Pharmaceutical Inc

Reuters
·
12 Jun

Collegium Pharmaceutical Inc. Files Initial Statement of Beneficial Ownership for Director Carlos V. Paya

Reuters
·
20 May

Collegium Pharmaceutical Approves 2025 Equity Incentive Plan

TIPRANKS
·
20 May

Collegium Pharmaceutical Inc. Conducted Annual Shareholders Meeting

Reuters
·
20 May

Collegium Pharmaceutical Inc. to Present at Jefferies Global Healthcare Conference

Reuters
·
20 May

Collegium Pharmaceutical Signs $25 Million Accelerated Share Buyback Deal With Jefferies

MT Newswires Live
·
12 May

Collegium Pharmaceutical Price Target Raised to $37.00/Share From $36.00 by Piper Sandler

Dow Jones
·
09 May

Collegium Pharmaceutical Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

Collegium Pharmaceutical Q1 Adj. EPS $1.49 Beats $1.43 Estimate, Sales $177.76M Beat $171.96M Estimate

Benzinga
·
09 May

BRIEF-Collegium Pharmaceutical Q1 Revenue USD 177.8 Million Vs. IBES Estimate USD 172 Million

Reuters
·
09 May

Collegium Pharmaceutical Q1 Revenue USD 177.8 Million VS. Ibes Estimate USD 172 Million

THOMSON REUTERS
·
09 May

Collegium Pharmaceutical Inc - Board of Directors Authorized $25.0 Mln Accelerated Share Repurchase Program

THOMSON REUTERS
·
09 May

Collegium Pharmaceutical Inc - Reaffirmed Full-Year 2025 Guidance

THOMSON REUTERS
·
09 May

Collegium Pharmaceutical (COLL) Expected to Beat Earnings Estimates: Should You Buy?

Zacks
·
01 May

Piper Sandler Sticks to Its Hold Rating for Collegium Pharmaceutical (COLL)

TIPRANKS
·
29 Apr

3 Healthcare Stocks That Concern Us

StockStory
·
28 Apr

Collegium Pharmaceutical Price Target Maintained With a $46.00/Share by Needham

Dow Jones
·
09 Apr

Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) 30% ROE Better Than Average?

Simply Wall St.
·
02 Apr

A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack

StockStory
·
02 Apr